AI assistant
RESMED INC — Director's Dealing 2022
Jan 4, 2022
30071_dirs_2022-01-04_a34523a1-1d17-4870-b942-1ac83313bc50.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2021-11-16
Reporting Person: Leong Justin (President, Asia Latin America)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-11-16 | ReMed Common Stock | A | 9162 | $254.81 | Acquired | 49857 | Direct |
| 2021-12-31 | ReMed Common Stock | F | 562 | $259.47 | Disposed | 49295 | Direct |
| 2021-11-18 | ReMed Common Stock | A | 638 | — | Acquired | 49933 | Direct |
Footnotes
F1: Represents performance-based restricted stock units granted on November 14, 2018. The shares were earned on November 16, 2021, when the compensation committee certified that the performance metrics were met
F2: Amended to report the disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/14/2018, 11/21/2019 and 11/19/2020.
F3: Represents performance-based restricted stock units granted on November 19, 2020. The shares were earned on November 18, 2021, when the compensation committee certified that the performance metrics were met for this portion of the grant. The earned units remain subject to time-vesting requirements, and are scheduled to vest on the three-year anniversary of the grant, assuming continued service through the vesting date.